ArticleBMC nephrology2024

Assessing antiviral treatment efficacy and risk factors for severe COVID-19 in kidney transplant recipients during the Omicron subvariant-dominant period: a retrospective study.

Takashi Sakaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.